Theriva Biologics, Inc. (TOVX) Tops Q1 EPS by 2c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q1 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• AI and memory not a classic bubble, but future returns uncertain - strategist
• Fastly’s 14% AI spike was a mirage; Here’s the edge stock Citi says you should own
• Costco (COST) Tops Q4 EPS by 20c